Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adachi S, Nakano T, Vliagoftis H, Metcalfe DD (1999) Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone. J Immunol 163:3363–3368
Aebischer I, Stampfli MR, Zurcher A, et al (1994) Neuropeptides are potent modulators of human in vitro immunoglobulin Esynthesis. Eur J Immunol 24:1908–1913
Aebischer I, Stämpfli M, Miescher S, Horn M, Zürcher AW, Stadler BM (1995) Neuropeptides accentuate interleukin-4 induced human immunoglobulin E synthesis in vitro. Exp Dermatol 4:418–423
Andersen GN, Hagglund M, Nagaeva O, et al (2005) Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3 and 5 and pro-opio-melanocortin peptide gene expression in subsets of human peripheral blood leucocytes. Scand J Immunol 61:279–284
Artuc M, Grutzkau A, Luger T, Henz BM (1999) Expression of MCI- and MC5-receptors on the human mast cell line HMC-1. Ann NY Acad Sci 885:364–367
Becher E, Mahnke K, Brzoska T, Kalden DH, Grabbe S, Luger TA (1999) Human peripheral blood-derived dendritic cells express functional melanocortin receptor MC-1R. Ann NY Acad Sci 885:188–195
Bhardwaj RS, Schwarz A, Becher E, et al (1996) Pro-opi-omelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 156:2517–2521
Bhardwaj RS, Becher E, Mahnke K, et al (1997) Evidence for the differential expression of the functional alpha melanocyte stimulating hormone receptor MC-1 on human monocytes. J Immunol 158:3378–3384
Böhm M, Raghunath M, Sunderkötter C et al (2004) Collagen metabolism is novel target of the neuropeptide α-melanocyte stimulating hormone. J Biol Chem 279:6959–6966
Böhm M, Schulte U, Kalden DH, Luger TA (1999) Alphamelanocyte-stimulating hormone modulates activation of NF-kB and AP-1 and secretion of IL-8 in human dermal fibroblasts. Ann N Y Acad Sci 885:277–286
Bohm M, Eickelmann M, Li Z, et al (2005) Detection of functionally active melanocortin receptors and evidence for an immunoregulatory activity of alpha-melanocyte-stimulating hormone in human dermal papilla cells. Endocrinology 146:4635–4646
Böhm M, Luger TA, Tobin DJ, Garcia-Borron JC (2006) Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J Invest Dermatol 126:1966–1975
Böhm M, Raap U, Schiller M, Straub RH, Haas H, Slominski A, Kapp A, Luger TA (2007) Expression and functional significance of HPA axis components in human basophils. Exp Dermatol 16:371–372 (abstract)
Brzoska T, Scholzen T, Becher E, Luger TA (1997) Effect of UV light on the production of proopiomelanocortinderived peptides and melanocortin receptors in the skin. In: Altmeyer P, Hoffmann K, Stücker M (eds) Skin Cancer and UV-Radiation. Springer-Verlag, Berlin, pp 227–237
Brzoska T, Kalden DH, Scholzen T, Luger TA (1999) Molecular basis of α-MSH/IL-1 antagonism. Ann NY Acad Sci 885:230–238
Brzoska T, Luger TA, Maaser C, Abels C, Böhm M (2008) (X-Melanocyte-stimulating hormone and related tripeptides. Biochemistry, anti-inflammatory effects in vitro and in vivo and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 29:581–602
Buzzetti R, McLoughlin L, Lavender PM, Clark AJ, Rees LH (1989) Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J Clin Invest 83:733–737
Candille SI, Kaelin CB, Cattanach BM, et al (2007) A defensin mutation causes black coat color in domestic dogs. Science 318:1418–1423
Cannon JG, Tatro JB, Reichlin S, Dinarello CA (1986) Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol 137:2232–2236
Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, Lipton JM (1996) The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17:675–679
Ceriani G, Macaluso A, Catania A, Lipton JM (1994) Central neurogenic antiinflammatory action of alpha-MSH: modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology 59:138–143
Ceriani G, Diaz J, Murphree S, Catania A, Lipton JM (1994) The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1:28–32
Cooper A, Robinson SJ, Pickard C, Jackson CL, Friedmann PS, Healy E (2005) Alpha-melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status. J Immunol 175:4806–4813
Dalmasso G, Charrier-Hisamuddin L, Thu Nguyen HT, Yan Y, Sitaraman S, Merlin D (2008) PepTl-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology 134:166–178
Denko CW, Gabriel P (1985) Effects of peptide hormones in urate crystal inflammation. J Rheumatol 12:971–975
Eipper BA, Mains RE (1980) Structure and biosynthesis of pro-adrenocorticotropin/endorphin and related peptides. Endocr Rev 1:1–27
Getting SJ, Flower RJ, Perretti M (1999) Agonism at melanocortin receptor type 3 on macrophages inhibits neutrophil influx. Inflamm Res 48(Suppl 2):S140–S141
Getting SJ, Gibbs L, Clark AJ, Flower RJ, Perretti M (1999) POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J Immunol 162:7446–7453
Getting SJ, Allcock GH, Flower R, Perretti M (2001) Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J Leukoc Biol 69:98–104
Getting SJ, Christian HC, Flower RJ, Perretti M (2002) Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 46:2765–2775
Getting SJ, Christian HC, Lam CW, et al (2003) Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor. J Immunol 170:3323–3330
Gonzalez-Rey E, Chorny A, Delgado M (2007) Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat Rev Immunol 7:52–63
Grabbe S, Bhardwaj RS, Steinert M, et al (1996) Alpha-melanocyte stimulating hormone induces hapten-specific tolerance in mice. J Immunol 156:473–478
Grutzkau A, Henz BM, Kirchhof L, Luger T, Artuc M (2000) Alpha-melanocyte stimulating hormone acts as a selective inducer of secretory functions in human mast cells. Biochem Biophys Res Commun 278:14–19
Gupta AK, Diaz RA, Higham S, Kone BC (2000) Alpha-MSH inhibits induction of C/EBPbeta-DNA binding activity and NOS2 gene transcription in macrophages. Kidney Int 57:2239–2248
Han D, Tian Y, Zhang M, Zhou Z, Lu J (2007) Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139–151-specificT cells. Gene Ther 14:383–395
Hartmeyer M, Scholzen T, Becher E, et al (1997) Human micro-vascular endothelial cells (HMEC-1) express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with αMSH. J Immunol 159:1930–1937
Haskell-Luevano C, Sawyer TK, Hendrata S, et al (1996) Truncation studies of alpha-melanotropin peptides identify tripeptide analogues exhibiting prolonged agonist bioactivity. Peptides 17:995–1002
Hiltz ME, Lipton JM (1990) Alpha-MSH peptides inhibit acute inflammation and contact sensitivity. Peptides 11:979–982
Hiltz ME, Catania A, Lipton JM (1992) Alpha-MSH peptides inhibit acute inflammation induced in mice by rIL-1 beta, rIL-6, rTNF-alpha and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8. Cytokine 4:320–328
Huang QH, Hruby VJ, Tatro JB (1998) Systemic alpha-MSH suppresses LPS fever via central melanocortin receptors independently of its suppression of corticosterone and IL-6 release. Am J Physiol 275:R524–R530
Kannengiesser K, Maaser C, Heidemann J, et al (2008) Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis 14:324–331
Lam CW, Getting SJ (2004) Melanocortin receptor type 3 as a potential target for anti-inflammatory therapy. Curr Drug Targets Inflamm Allergy 3:311–315
Lipton JM, Catania A (1997) Antiinflammatory actions of the neuroimmunomodulator α-MSH. Immunol Today 18:140–145
Loser K, Brzoska T, Beissert S, Luger TA (2006) α-Melanocyte stimulating hormone treated CD8+ T cells control contact allergy and anti-tumoral immunity. J Invest Dermatol 126:109 (Abstract)
Loser K, Brzoska T, Kupas V, Höcker N, Voskort M, Beissert S, Abels Ch, Luger TA (2008) α-Melanocyte stimulating hormone induces tolerogenic dendritic cells that generate CD4+ regulatory T cells. J Invest Dermatol 128:iii (Abstract)
Luger TA, Schauer E, Trautinger F, et al (1993) Production of immunosuppressing melanotropins by keratinocytes. Ann N Y Acad Sci 680:567–570
Maaser C, Kannengiesser K, Specht C, et al (2006) Crucial role of the melanocortin receptor MC1R in experimental colitis. Gut 55:1415–1422
Manna SK, Aggarwal BB (1998) α-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kB activation induced by various inflammatory agents. J Immunol 161:2873–2880
Manna SK, Ramesh GT (2005) Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway. J Biol Chem 280:7010–7021
Manna SK, Sarkar A, Sreenivasan Y (2006) Alpha-melanocyte-stimulating hormone down-regulates CXC receptors through activation of neutrophil elastase. Eur J Immunol 36:754–769
Moustafa M, Szabo M, Ghanem GE, et al (2002) Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides. J Invest Dermatol 119:1244–1253
Mugridge KG, Perretti M, Ghiara P, Parente L (1991) Alpha-melanocyte-stimulating hormone reduces interleukin-1 beta effects on rat stomach preparations possibly through interference with a type I receptor. Eur J Pharmacol 197:151–155
Namba K, Kitaichi N, Nishida T, Taylor AW (2002) Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2. J Leukoc Biol 72:946–952
Nicolaou A, Estdale SE, Tsatmali M, Herrero DP, Thody AJ (2004) Prostaglandin production by melanocytic cells and the effect of alpha-melanocyte stimulating hormone. FEBS Lett 570:223–226
Nishida T, Miyata S, Itoh Y, et al (2004) Anti-inflammatory effects of alpha-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor. Int Immunopharmacol 4:1059–1066
Oktar BK, Ercan F, Yegen BC, Alican I (2000) The effect of alpha-melanocyte stimulating hormone on colonic inflammation in the rat. Peptides 21:1271–1277
Raap U, Brzoska T, Sohl S, et al (2003) Alpha-melanocyte-stimulating hormone inhibits allergie airway inflammation. J Immunol 171:353–359
Raap U, Schefzyk M, Bruder M, Schiller M, Luger TA, Kapp A, Böhm M (2007) The eosinophil — a novel target for the neuropeptide alpha-melanocyte-stimulating hormone. Exp Dermatol 16:377–378 (Abstract)
Rajora N, Ceriani G, Catania A, Star RA, Murphy MT, Lipton JM (1996) Alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J Leukoc Biol 59:248–253
Rajora N, Boccoli G, Catania A, Lipton JM (1997) Alpha-MSH modulates experimental inflammatory bowel disease. Peptides 18:381–385
Redondo P, Garcia-Foncillas J, Okroujnov I, Bandres E (1998) α-MSH regulates interleukin-10 expression by human keratinocytes. Arch Dermatol Res 290:425–428
Rheins LA, Cotleur AL, Kleier RS, Hoppenjans WB, Sauder DN, Nordlund JJ (1989) Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J Invest Dermatol 93:511–517
Sarkar A, Sreenivasan Y, Manna SK (2003) Alpha-melanocyte-stimulating hormone inhibits lipopolysaccharide-induced biological responses by downregulating CD 14 from macrophages. FEBS Lett 553:286–294
Schioth HB, Muceniece R, Larsson M, et al (1997) Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. Eur J Pharmacol 319:369–373
Scholzen TE, Sunderkotter C, Kalden DH, et al (2003) Alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology 144:360–370
Seidah NG, Benjannet S, Hamelin J, et al (1999) The sub-tilisin/kexin family of precursor convertases. Emphasis on PCI, PC2/7B2, POMC and the novel enzyme SKI-1. Ann NY Acad Sci 885:57–74
Slominski A, Wortsman J, Luger T, Paus R, Solomon S (2000) Corticotropin releasing hormone and proopi-omelanocortin involvement in the cutaneous response to stress. Physiol Rev 80:979–1020
Star RA, Rajora N, Huang J, Chavez R, Catania A, Lipton JM (1995) Evidence of autocrine modulation of macro-phage nitric oxide synthase by alpha-MSH. Proc Natl Acad Sci USA 92:8016–8020
Suzuki I, Tada A, Ollmann MM, et al (1997) Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin. J Invest Dermatol 108:838–842
Taherzadeh S, Sharma S, Chhajlani V, et al (1999) Alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte/macrophages. Am J Physiol 276:R1289–R1294
Taylor AW (2005) The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) sup-presses LPS-stimulated TLR4 with IRAK-M in macro-phages. J Neuroimmunol 162:43–50
Taylor AW, Kitaichi N (2008) The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy. Brain Behav Immun 22:639–646
Taylor AW, Streilein JW, Cousins SW (1994) Alpha-melanocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon. Neuroimmunomodulation 1:188–194
Taylor AW, Yee DG, Nishida T, Namba K (2000) Neuropeptide regulation of immunity. The immunosup-pressive activity of alpha-melanocyte-stimulating hormone (alpha-MSH). Ann NY Acad Sci 917:239–247
Wong KY, Rajora N, Boccoli G, Catania A, Lipton JM (1997) A potential mechanism of local anti-inflammatory action of alpha-melanocyte-stimulating hormone within the brain: modulation of tumor necrosis factor-alpha production by human astrocytic cells. Neuroimmunomodulation 4:37–41
Yoon SW, Goh SH, Chun JS, et al (2003) Alpha-melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. J Biol Chem 278:32914–32920
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Luger, T.A., Brzoska, T., Loser, K., Böhm, M. (2009). Regulation of Immune Cells by POMC Peptides. In: Granstein, R.D., Luger, T.A. (eds) Neuroimmunology of the Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-35989-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-540-35989-0_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-35986-9
Online ISBN: 978-3-540-35989-0
eBook Packages: MedicineMedicine (R0)